About US
Contact us
-
SFDA exposes 14 illegal drug websitesThe State Food and Drug Administration (SFDA) recently issued 2010 Second Safety Warning Announcement Regarding Buying Medicines Online and exposed 14 websites releasing false drug information and s2010/8/17
-
Eli Lilly to appeal against U.S. District Court ruling in Strattera patent litigationEli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the District of New Jersey has ruled against the company in its patent litigation for Strattera® (atomoxetine). I2010/8/16
-
Lamictal can cause aseptic meningitis: FDAThe U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protec2010/8/16
-
Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPsBristol-Myers Squibb Company (NYSE: BMY) and the ADAP Crisis Task Force (ACTF) today announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs (ADAPs) to provide antiretr2010/8/13
-
Simcere subsidiary receives Chinese SFDA approval to manufacture and market PalonosetronSimcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary2010/8/13
-
Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize EplerenoneSinobiopharma, Inc. (OTCBB:SNBP) ("Sinobiopharma" or the "Company"), an innovative biopharmaceutical products company with primary operations in China, today announced that the Company, through its wh2010/8/12
-
Nabi Biopharmaceuticals completes sale of PentaStaph vaccine candidate to GSKNabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has successfully completed the technology transfer of program know-how associated with the sale of the PentaStaphTM vaccine candidate to G2010/8/12
-
Weifang Shengtai to supply Kelun with 10,000 tons of dextrose monohydrate injection gradeShengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) announced on August 6, 2010 that Weifang Shengtai Pharmaceutical Co., Ltd ("Weifang Shengtai"), its operating subsidiary in China, entered into2010/8/11
-
FDA grants Orphan Drug Designation to YM BioSciences' JAK1/2 inhibitor-JAK1/2 inhibitor currently in Phase II clinical study in myelofibrosis- YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announced that the Office of Orphan Products Development of the U.S. Food and Dr2010/8/11
-
Mephedrone regulated as psychotropic substancesOn August 2, 2010, the State Food and Drug Administration, the Ministry of Public Security and the Ministry of Health jointly issued an announcement, which requires that Mephedrone (4-methylmethcath2010/8/10